Apply to trial NCT05885503

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 3Biological intervention

Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema

The purpose of this study is to evaluate efficacy and safety of RC28-E compared with Aflibercept in subjects with diabetic macular edema.

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We forward your profile to the study team

    They see only the answers needed to decide if you can be screened.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email so you can come back later, and the study team uses it to reach you.

By clicking Start, you agree to our terms of service.